Bayer Ordered to Pay $78 Million in Roundup Cancer Verdict
A Philadelphia jury finds Bayer liable for a Pennsylvania man's cancer, awarding significant punitive damages.
- William Melissen, who used Roundup for nearly 30 years, was diagnosed with non-Hodgkin's lymphoma in 2020.
- The jury awarded Melissen $3 million in compensatory damages and $75 million in punitive damages.
- Bayer plans to appeal the verdict, arguing the decision contradicts scientific consensus and regulatory findings.
- Bayer has faced multiple lawsuits over Roundup, settling most claims in 2020 for $10.9 billion but still contending with about 58,000 claims.
- The case highlights ongoing legal battles and conflicting court rulings regarding the safety of glyphosate, Roundup's active ingredient.